Cargando…
Mesenchymal stem cell therapy for ischemic stroke: Novel insight into the crosstalk with immune cells
Stroke, a cerebrovascular accident, is prevalent and the second highest cause of death globally across patient populations; it is as a significant cause of morbidity and mortality. Mesenchymal stem cell (MSC) transplantation is emerging as a promising treatment for alleviating neurological deficits,...
Autores principales: | Tan, Nana, Xin, Wenqiang, Huang, Min, Mao, Yuling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679024/ https://www.ncbi.nlm.nih.gov/pubmed/36425795 http://dx.doi.org/10.3389/fneur.2022.1048113 |
Ejemplares similares
-
Modulatory effects of mesenchymal stem cells on microglia in ischemic stroke
por: Hao, Lei, et al.
Publicado: (2023) -
The role of mesenchymal stem cell transplantation for ischemic stroke and recent research developments
por: Zhou, Li, et al.
Publicado: (2022) -
Safety and Efficacy of Stem Cell Therapy in Patients With Ischemic Stroke
por: Gautam, Jeevan, et al.
Publicado: (2020) -
Stem Cell Therapies for Ischemic Stroke: A Systematic Review
por: Abdullahi, Abba Musa, et al.
Publicado: (2021) -
Dental Pulp Stem Cells: An Attractive Alternative for Cell Therapy in Ischemic Stroke
por: Lan, Xiaoyan, et al.
Publicado: (2019)